AL
GHDX

AJO LP’s Genomic Health, Inc. GHDX Stock Holding History

AJO LP’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-150,359
Closed -$4.74M – 668
2017
Q1 		$4.74M Buy
+150,359
New +$4.45M 0.02% 289
2015
Q3 		– Sell
-9,760
Closed -$271K – 570
2015
Q2 		$271K Buy
+9,760
New +$275K ﹤0.01% 495

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

AJO LP's GHDX Position: Q2 2017 in Review

AJO LP sold out of Genomic Health, Inc. (GHDX) in Q2 2017, closing a stake of 150,359 shares — an estimated $4.74M sold.

AJO LP first reported a position in GHDX in Q2 2015 and held it in 2 quarters. The position peaked at $4.74M in Q1 2017. 124 funds tracked by Wall St. Rank hold GHDX as of Q2 2017.

  • AJO LP reported no remaining Genomic Health, Inc. position as of Q2 2017 after selling out during the quarter.
  • AJO LP sold 150,359 Genomic Health, Inc. shares in Q2 2017, an estimated $4.74M.
  • AJO LP first reported a position in Genomic Health, Inc. in Q2 2015 and held it in 2 quarters.
  • AJO LP's Genomic Health, Inc. position peaked at $4.74M in Q1 2017.
  • 124 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2017.

Based on AJO LP's 13F filing for Q2 2017, filed 10 Aug 2017.